Clay Thorp's Net Worth

$78.4 Million

Estimate Recalculated Jul 3, 2024 04:36PM EST

Who is Clay Thorp?

Clay Thorp has an estimated net worth of $78.4 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., G1 Therapeutics, Inc., PhaseBio Pharmaceuticals Inc, and Clearside Biomedical, Inc..

SEC CIK

Clay Thorp's CIK is 0001592380

Past Insider Trading and Trends

2018 was Clay Thorp's most active year for acquiring shares with 16 total transactions. Clay Thorp's most active month to acquire stocks was the month of May. 2017 was Clay Thorp's most active year for disposing of shares, totalling 45 transactions. Clay Thorp's most active month to dispose stocks was the month of September. 2016 saw Clay Thorp paying a total of $9,151,904.04 for 7,912,189 shares, this is the most they've acquired in one year. In 2018 Clay Thorp cashed out on 3,412,259 shares for a total of $44,133,742.53, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Clearside Biomedical, Inc. (CLSD) Snapshot price: $1.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
+32.76%
10K
$0.86
$8,600.00
40.52K
Sep 25
Form 4
—
0
—
—
0
Jun 22
Form 4
+84.74%
14K
$1.02
$14,266.00
30.52K
Dec 21
Form 4
-28.19%
-1.40M
—
—
3.56M
Dec 15
Form 4/A
-0.66%
-32.87K
$4.43
-$145,627.39
4.95M
Scheduled
Feb 10
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 10
Form 4
-0.95%
-32.87K
$4.43
-$145,627.39
3.43M
Scheduled
Feb 10
Form 4
—
0
—
—
0
Jun 18
Form 4
+43.79%
1.52M
$1.05
$1,599,999.40
4.98M
Nov 22
Form 4
—
0
—
—
0
Jun 20
Form 4
∞
8K
$1.36
$10,880.00
8K
Dec 6
Form 4
—
0
—
—
0
Jun 20
Form 4
-4.44%
-161.14K
$13.08
-$2,107,589.24
3.47M
May 17 - May 18
Form 4
-3.69%
-138.86K
$12.21
-$1,695,790.72
3.63M
Mar 21 - Mar 23
Form 4
-0.92%
-35.00K
$6.22
-$217,550.00
3.77M
Scheduled
Dec 5 - Dec 7
Form 4
-0.91%
-35.00K
$7.00
-$245,100.00
3.8M
Scheduled
Nov 14 - Nov 16
Form 4
-0.90%
-35.00K
$8.57
-$299,900.00
3.84M
Scheduled
Oct 3 - Oct 5
Form 4
-0.63%
-24.50K
$7.52
-$184,185.00
3.87M
Scheduled
Sep 13 - Sep 15
Form 4
-0.62%
-24.50K
$7.57
-$185,490.00
3.9M
Scheduled
Aug 7 - Aug 9
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 22
Form 4
-0.61%
-24.00K
$8.36
-$200,610.00
3.92M
Scheduled
May 18 - May 19
Form 4
-1.12%
-44.48K
$8.63
-$384,096.38
3.94M
Scheduled
May 15 - May 17
Form 4
-1.69%
-68.48K
$7.46
-$510,944.50
3.99M
Scheduled
Apr 17 - Apr 19
Form 4
-1.66%
-68.48K
$6.56
-$449,543.45
4.06M
Scheduled
Mar 15 - Mar 16
Form 4
-0.65%
-27.00K
$7.55
-$203,730.00
4.13M
Scheduled
Feb 21 - Feb 22
Form 4
-0.99%
-41.48K
$7.60
-$315,105.40
4.15M
Scheduled
Feb 15 - Feb 17
Form 4
-1.61%
-68.48K
$8.53
-$584,001.55
4.19M
Scheduled
Jan 17 - Jan 20
Form 4
-1.42%
-29.66K
$8.63
-$255,784.88
2.06M
Jan 17 - Jan 19
Form 4
-1.42%
-25.30K
$8.63
-$218,222.36
1.76M
Jan 17 - Jan 19
Form 4
+3,082.66%
1.73M
$6.41
-$483.00
1.78M
Jun 7
Form 4
+3,630.78%
2.03M
$6.83
-$483.00
2.09M
Jun 7
Form 4
+3,704.46%
4.15M
$6.82
-$966.00
4.26M
Jun 7
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

G1 Therapeutics, Inc. (GTHX) Snapshot price: $4.7901

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.81%
-800.00K
$48.00
-$38,400,000.00
3.24M
May 30
Form 4
-0.92%
-37.50K
$51.11
-$1,916,677.56
4.04M
May 21 - May 23
Form 4
-2.36%
-98.52K
—
—
4.08M
Nov 30
Form 4
∞
4.17M
$15.00
—
4.17M
May 22
Form 3
—
0
—
—
0
No matching records found

Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.88

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.42%
36.7K
$2.85
$104,410.50
1.56M
May 16 - May 17
Form 4
∞
3K
$7.20
$21,604.20
3K
Mar 28
Form 4
∞
1.52M
$14.00
—
1.52M
Jan 11
Form 3
—
0
—
—
0
No matching records found

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.38%
3.75K
—
—
36.69K
May 19
Form 4
—
0
—
—
0
May 19
Form 4
+43.59%
10K
$3.00
$30,000.00
32.94K
Aug 18
Form 4
—
0
—
—
0
Jun 3
Form 4
+27.87%
5K
$3.60
$18,010.00
22.94K
Nov 23 - Nov 24
Form 4
-54.31%
-39.67K
—
—
33.38K
Nov 16
Form 4
—
0
—
—
0
Jun 3
Form 4
-0.12%
-2.91K
$14.00
-$40,712.00
2.45M
Scheduled
Jul 1
Form 4
-0.02%
-400.00
$14.00
-$5,600.00
2.45M
Scheduled
Jun 18
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
Feb 27
Form 4
+33.90%
4K
$3.13
$12,520.00
15.8K
Dec 4
Form 4
∞
2.46M
$5.00
—
2.46M
Oct 22
Form 3
—
0
—
—
0
No matching records found